Sort
16,300 grants matching “fatty liver disease”
Role of G protein-coupled receptors in regulating glucose and energy homeostasis
$3,184,111Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Transcriptional co-regulators and macrophage gene expression
$3,078,559Christopher K Glass · University Of California, San Diego · R01 · FY2025 · DK
Engineered metabolite-based nanoparticles for immunomodulation of macrophages to treat obesity
$3,065,252Alireza Hassani Najafabadi · Terasaki Institute For Biomedical Innovation · R01 · FY2025 · DK
The Connie Wofsy Women's HIV Study
$3,055,971Ruth Martha Greenblatt · University Of California, San Francisco · U01 · FY2007 · AI
RNA modifications in apolipoprotein regulation by environmental exposures
$3,051,769Carolyn M. Klinge · University Of Louisville · R01 · FY2025 · ES
Mechanisms, modeling and therapies of retinal and macular neurodegeneration
$3,007,068Anand Swaroop · National Eye Institute · ZIA · FY2022 · EY
Regulation of mitochondrial health in mammalian livers.
$2,999,512Prashant Mishra · Ut Southwestern Medical Center · R01 · FY2025 · DK
Mechanism and biological consequences of the nuclear receptor CAR activation
$2,990,301Masahiko Negishi · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases
$2,978,290Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Translational control underlies nutrition and metabolism in health and disease
$2,971,227Davide Ruggero · University Of California, San Francisco · R01 · FY2025 · DK
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,962,553Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
University of Pennsylvania HIV Clinical Trials Unit
$2,946,326Ian Frank · University Of Pennsylvania · UM1 · FY2024 · AI
Optimal Selective Thyroid Hormone Analogs for Metabolic Syndrome
$2,921,456Paul Webb · Methodist Hospital Research Institute · RC4 · FY2010 · DK
1/2 REPRIEVE Extension for Trial Completion
$2,903,944Steven Kyle Grinspoon · Massachusetts General Hospital · UG3 · FY2025 · HL
GE Healthcare Discovery MR750 3T MRI System
$2,848,680Frank Korosec · University Of Wisconsin-Madison · S10 · FY2010 · RR
Metabolic Syndrome, Inflammation and Vascular Remodeling
$2,830,751Francine K Welty · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL
Clinical Genomics and Experimental Therapeutics
$2,830,248Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer
$2,809,173Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
University of Pennsylvania HIV Clinical Trials Unit
$2,761,412Ian Frank · University Of Pennsylvania · UM1 · FY2025 · AI
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$2,750,000Darby Thompson · The Emmes Company, Llc · N01 · FY2011 · EY
Investigations of Methylmalonic Acidemia and Related Disorders
$2,733,586Charles P Venditti · National Human Genome Research Institute · ZIA · FY2024 · HG
Framingham Project/Levy
$2,722,934Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Molecular Pathogenesis of Rodent Neoplasia
$2,714,757Arun Kumar Pandiri · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,696,586Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Molecular Pathogenesis of Rodent Neoplasia
$2,692,938Arun Kumar Pandiri · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES